General News

The 2025 share price range, running from approximately GBX262 to GBX598 according to publicly available market data, illustrates just how volatile the stock has been. ThatVolatilityis the result of a basket of moving parts: copper grades at key operations, steelmaking and energy coal prices, …

This article reviews Fresnillo's recent results, share price performance andCapital-return record, alongside the operational and macro forces that could shape the next phase of its story.

Experian(LSE:EXPN) does not always grab headlines like the FTSE 100's banks or oil majors. Yet for many UK investors, this Ireland-headquartered, London-listedCreditdata and analytics group has become one of theindex's most reliable structural growth stories. With its FY25 results showing 8%Revenuegrowth and the FY26 …

Haleon(LSE:HLN) is the world’s largest pure-play consumer healthBusiness, home to global brands including Sensodyne, parodontax, Panadol, Voltaren, Advil, Centrum, Theraflu and Otrivin. Spun out of GSK in 2022, the FTSE 100 group has spent the past three years building its own identity as a …

After the consumer healthBusinesswas demerged as Haleon, GSK pitched itself to investors as a more focused biopharma company with deeper exposure to fast-growing therapy areas. The 2025 prints provide some of the strongest evidence to date that this strategy is bearing fruit, particularly in …

The headline from BP s Q4 and full-year 2025 results, published in February 2026, was that the company is willing to step back from one of the most popular tools in the oil majorShareholderreturn playbook. Suspending the buyback is a meaningful signal: it means …

From record group income to a fresh share buyback, Barclays sits at the intersection of several powerful themes: UK retail banking, USCreditcards, globalInvestment-banking/">Investment Bankingand the long-running debate about whether British banks are finally being repriced. According to company updates and recent share price moves, …